Recognizing the Role of Capmatinib for METex14 in NSCLC
Jacob Sands, MD
Edward B. Garon, MD, MS
Evaluating Landmark Clinical Data for HER2-low Breast Cancer
Pavani Chalasani, MD, MPH
Prof. David Cameron
Evaluating a Treatment for HER2-Positive Metastatic Breast Cancer
Erika Hamilton, MD
Updates on Breast Cancer Treatment: Exploring CDK4/6 Inhibitors & Endocrine Therapy
Kevin Kalinsky MD, MS
The Emerging Role of Immunotherapy in Triple-Negative Breast Cancer
Nan Chen, MD
Treating Metastatic Breast Cancer: Where Are We Now?
Seema A. Khan, MD
Exploring Drug Shortages in the U.S.: What Do We Need to Know?
Maya Leiva, PharmD, BCOP
Bridging the Gaps in Care: How to Improve Care for LGBTQ+ Patients
Conversations Around Chemotherapy: Do All of Your Patients Need It?
A Look at the Therapeutic Landscape for Metastatic Breast Cancer
Aditya Bardia, MD, MPH
Exploring the Treatment Landscape for Triple-Negative Breast Cancer
Research Shows Overdiagnosis of Melanoma in White Men & Women
A Look at HIV & Its Link to Cancer
Hepatocellular Carcinoma: Evaluating the Evolving Treatment Landscape
Manish A. Shah, MD FASCO
Closing the Gaps in Cancer Screening: Insights from the President's Cancer Panel
Edith Mitchell, MD, MACP, FCPP, FRCP
Anesthesia Technique & Cancer Recurrence: What Do We Need to Know?
Daniel Sessler, MD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.